BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28572675)

  • 1. Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.
    Ye H; Shao M; Shi X; Wu L; Xu B; Qu Q; Qu J
    Sci Rep; 2017 Jun; 7(1):2670. PubMed ID: 28572675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Wu G; Jiang B; Liu X; Shen Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer.
    Jia W; Sun JY; Jia KY; Liu XC
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Wang H; Gao X; Zhang X; Gong W; Peng Z; Wang B; Wang L; Chang S; Ma P; Wang S
    Med Sci Monit; 2018 Oct; 24():7482-7492. PubMed ID: 30341887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.
    Pereira D; Assis J; Gomes M; Nogueira A; Medeiros R
    Eur J Clin Pharmacol; 2016 May; 72(5):545-53. PubMed ID: 26803611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferases genes variants and chemotherapy efficacy in gastrointestinal cancer patients: a meta-analysis based on 50 pharmacogenetic studies.
    Sun Y; Pan J; Tong X; Chen E; Yan W; Wu M; Qu Q; Qu J
    J Cancer; 2019; 10(13):2915-2926. PubMed ID: 31281468
    [No Abstract]   [Full Text] [Related]  

  • 8. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    Zhang WP; Yang C; Xu LJ; Wang W; Song L; He XF
    Medicine (Baltimore); 2021 Jul; 100(26):e26104. PubMed ID: 34190143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population.
    Xiao HL; Yang ZT; Han F; Wei HX
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis.
    Yang Y; Xian L
    Tumour Biol; 2014 Jul; 35(7):6791-9. PubMed ID: 24729086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
    Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
    Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
    Kong X; Li Z; Li X
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.
    Wang X; Huang ZH
    Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.